• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD

ZELIRA THERAPEUTICS LIMITED - Announcements

7.32% ! 38.0¢
Market Cap $4.520M  !

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Announcements



ZLD US Autism Observational Study UnderwayPRICE SENSITIVE10/10/18 download Created with Sketch. 221.44KB
ZLD First Patient Dosed in Zelda Insomnia TrialPRICE SENSITIVE26/09/18 download Created with Sketch. 121.51KB
ZLD Investor Presentation - Non-deal Roadshow25/09/18 download Created with Sketch. 5.57MB
ZLD Zelda Forms New Partnership to Access German MarketPRICE SENSITIVE04/09/18 download Created with Sketch. 142.53KB
ZLD Appendix 4G31/08/18 download Created with Sketch. 122.15KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE31/08/18 download Created with Sketch. 953.66KB
ZLD Appendix 3B22/08/18 download Created with Sketch. 149.64KB
ZLD Two Key Clinical Appointments to Medical Advisory Board22/08/18 download Created with Sketch. 128.87KB
ZLD June 2018 Quarterly ReportPRICE SENSITIVE30/07/18 download Created with Sketch. 126.27KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/07/18 download Created with Sketch. 75.55KB
ZLD Initial Director's Interest Notice16/07/18 download Created with Sketch. 30.18KB
ZLD Commencement of New Managing DirectorPRICE SENSITIVE16/07/18 download Created with Sketch. 159.29KB
ZLD Paediatric Brain Cancer Research Update06/06/18 download Created with Sketch. 146.6KB
ZLD Details of Company Address25/05/18 download Created with Sketch. 113.53KB
ZLD Appointment of Managing DirectorPRICE SENSITIVE22/05/18 download Created with Sketch. 124.53KB
ZLD March 2018 Quarterly ReportPRICE SENSITIVE30/04/18 download Created with Sketch. 135.38KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/04/18 download Created with Sketch. 75.01KB
ZLD Insomnia Clinical Trial Update-Patient Recruitment CompletedPRICE SENSITIVE23/04/18 download Created with Sketch. 125.51KB
ZLD Research into Cannabinoids and Diabetes-Related Conditions18/04/18 download Created with Sketch. 126.79KB
ZLD US Autism Observational Study Receives IRB Approval13/04/18 download Created with Sketch. 144.11KB
ZLD Expansion of Pancreatic Cancer Research ProgrammePRICE SENSITIVE06/03/18 download Created with Sketch. 145.21KB
ZLD Appendix 4D & FY18 Interim Financial ReportPRICE SENSITIVE27/02/18 download Created with Sketch. 289.5KB
ZLD December 2017 Quarterly Report31/01/18 download Created with Sketch. 126.54KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/01/18 download Created with Sketch. 74.93KB
ZLD Shares Begin Trading in the USA on the OTCQB Venture Market22/01/18 download Created with Sketch. 123.81KB
ZLD Appendix 3B12/01/18 download Created with Sketch. 148.22KB
ZLD Cancellation of Unlisted Options10/01/18 download Created with Sketch. 86.22KB
ZLD Change of Director's Interest Notice20/12/17 download Created with Sketch. 73.48KB
ZLD Zelda joins with US Children's Hospital for autism studyPRICE SENSITIVE11/12/17 download Created with Sketch. 142.58KB
ZLD Trading HaltPRICE SENSITIVE08/12/17 download Created with Sketch. 364.62KB
ZLD Response to ASX Aware QueryPRICE SENSITIVE05/12/17 download Created with Sketch. 578.75KB
ZLD Australian Regulators Approve Zelda Insomnia Clinical TrialPRICE SENSITIVE29/11/17 download Created with Sketch. 127.02KB
ZLD Results of Meeting24/11/17 download Created with Sketch. 111.98KB
ZLD Annual General Meeting Presentation 201724/11/17 download Created with Sketch. 2.22MB
ZLD Chairman's Address - Annual General Meeting24/11/17 download Created with Sketch. 61.23KB
ZLD Response to ASX Price and Volume QueryPRICE SENSITIVE22/11/17 download Created with Sketch. 500.58KB
ZLD Trading HaltPRICE SENSITIVE21/11/17 download Created with Sketch. 308.37KB
ZLD Appendix 3B - Release of Securities from Escrow16/11/17 download Created with Sketch. 147.55KB
ZLD Release from Escrow01/11/17 download Created with Sketch. 89.4KB
ZLD September 2017 Quarterly Report31/10/17 download Created with Sketch. 123.1KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/10/17 download Created with Sketch. 80.31KB
ZLD Notice of Annual General Meeting26/10/17 download Created with Sketch. 97.72KB
ZLD Successful Results in Autism Observation TrialPRICE SENSITIVE18/09/17 download Created with Sketch. 122.86KB
ZLD Update on Closing Date of CannPal Priority Offer18/09/17 download Created with Sketch. 92.95KB
ZLD Update on Research Programme in Chile13/09/17 download Created with Sketch. 124.26KB
ZLD Appendix 4G31/08/17 download Created with Sketch. 113.46KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE31/08/17 download Created with Sketch. 822.26KB
ZLD CannPal Priority Share Offer Clarification Announcement31/08/17 download Created with Sketch. 91.75KB
ZLD Priority Share Offer for CannPal IPO Shares29/08/17 download Created with Sketch. 93.19KB
ZLD Company Presentation on 2017 Half Year Activities25/08/17 download Created with Sketch. 105.9KB
ZLD Expansion of Breast Cancer Research CollaborationPRICE SENSITIVE31/07/17 download Created with Sketch. 697.38KB
ZLD June 2017 Quarterly Report28/07/17 download Created with Sketch. 147.88KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE28/07/17 download Created with Sketch. 75.61KB
ZLD ENT:Acquisition of prospective Au& Cu/Zn Murchison TenementsPRICE SENSITIVE26/07/17 download Created with Sketch. 1016.08KB
ZLD Updated Securities Trading and Corporate Governance Policies30/06/17 download Created with Sketch. 180.34KB
ZLD Zelda Enters into Strategic Agreement with Knop LaboratoriesPRICE SENSITIVE15/06/17 download Created with Sketch. 175.29KB
ZLD Positive Results From Pre-Clinical Breast Cancer StudiesPRICE SENSITIVE02/06/17 download Created with Sketch. 228.16KB
ZLD March 2017 Quarterly ReportPRICE SENSITIVE28/04/17 download Created with Sketch. 405.15KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE28/04/17 download Created with Sketch. 240.11KB
ZLD Appendix 3B - Release of Securities from Escrow21/04/17 download Created with Sketch. 122.93KB
ZLD Clinical Research Programme to Expand to Include AutismPRICE SENSITIVE19/04/17 download Created with Sketch. 431.74KB
ZLD Change in substantial holding x 306/04/17 download Created with Sketch. 556.09KB
ZLD Appendix 3B05/04/17 download Created with Sketch. 125.25KB
ZLD Release from Escrow04/04/17 download Created with Sketch. 64.22KB
ZLD Cleansing ProspectusPRICE SENSITIVE03/04/17 download Created with Sketch. 211.79KB
ZLD Zelda Successfully Completes Capital RaisingPRICE SENSITIVE30/03/17 download Created with Sketch. 77.28KB
ZLD Trading HaltPRICE SENSITIVE28/03/17 download Created with Sketch. 289.56KB
ZLD Zelda Enters Strategic Partnership with CannPalPRICE SENSITIVE27/03/17 download Created with Sketch. 82.79KB
ZLD Clinical Trials to Commence in ChilePRICE SENSITIVE23/03/17 download Created with Sketch. 421.27KB
ZLD New Licence AgreementPRICE SENSITIVE21/03/17 download Created with Sketch. 106.58KB
ZLD Closure of Unmarketable Parcel Share Sale Facility14/03/17 download Created with Sketch. 63.09KB
ZLD Appendix 4D & FY17 Interim Financial ReportPRICE SENSITIVE27/02/17 download Created with Sketch. 250.99KB
ZLD Zelda Therapeutics to present activities update21/02/17 download Created with Sketch. 38.46KB
ZLD Investor Presentation08/02/17 download Created with Sketch. 631KB
ZLD Issue of Options under ESOP & Appendix 3B06/02/17 download Created with Sketch. 146.44KB
ZLD Quarterly Report and Appendix 4CPRICE SENSITIVE31/01/17 download Created with Sketch. 276.75KB
ZLD Unmarketable Parcel Share Sale Facility19/01/17 download Created with Sketch. 201.26KB
ZLD Appendix 3B11/01/17 download Created with Sketch. 122.66KB
ZLD Release from escrow11/01/17 download Created with Sketch. 26.2KB
ZLD Details of Company Address11/01/17 download Created with Sketch. 26.24KB
ZLD Shareholder Update09/01/17 download Created with Sketch. 87.19KB
ZLD Zelda to Test Formulations Against Pancreatic CancerPRICE SENSITIVE20/12/16 download Created with Sketch. 60.39KB
ZLD Company Secretary Appointment16/12/16 download Created with Sketch. 23.67KB
ZLD Sleep Disorder Clinical Trials UpdatePRICE SENSITIVE12/12/16 download Created with Sketch. 71.11KB
ZLD Collaboration Agreement with Telethon Kids InstitutePRICE SENSITIVE05/12/16 download Created with Sketch. 71.08KB
ZLD Significant Anti-Cancer Effect Observed in StudiesPRICE SENSITIVE30/11/16 download Created with Sketch. 152.06KB
ZLD Results of Meeting28/11/16 download Created with Sketch. 26.45KB
ZLD Becoming a substantial holder25/11/16 download Created with Sketch. 1.36MB
ZLD Change in substantial holding25/11/16 download Created with Sketch. 1.46MB
ZLD Change in substantial holding25/11/16 download Created with Sketch. 92.13KB
ZLD Zelda expands its Intellectual Property portfolioPRICE SENSITIVE25/11/16 download Created with Sketch. 340.99KB
ZLD Becoming a substantial holder23/11/16 download Created with Sketch. 165.31KB
ZLD OpenBriefing Recording with Dr Stewart WasherPRICE SENSITIVE23/11/16 download Created with Sketch. 63.19KB
ZLD Investor Presentation22/11/16 download Created with Sketch. 1.47MB
ZLD Zelda Therapeutics Debuts on ASX22/11/16 download Created with Sketch. 73.19KB
ZLD Zelda Therapeutics Pty Ltd - 30 June 2016 Accounts18/11/16 download Created with Sketch. 302.6KB
ZLD Zelda Therapeutics Pty Ltd - 31 December 2015 Accounts18/11/16 download Created with Sketch. 1.27MB
ZLD Updated Pro-Forma Statement18/11/16 download Created with Sketch. 158.87KB
ZLD Updated Statement of Commitments18/11/16 download Created with Sketch. 362.28KB
ZLD Confirmations18/11/16 download Created with Sketch. 31.94KB
ZLD US Autism Observational Study Underway
10/10/18PRICE SENSITIVE download Created with Sketch. 221.44KB
ZLD First Patient Dosed in Zelda Insomnia Trial
26/09/18PRICE SENSITIVE download Created with Sketch. 121.51KB
ZLD Investor Presentation - Non-deal Roadshow
25/09/18 download Created with Sketch. 5.57MB
ZLD Zelda Forms New Partnership to Access German Market
04/09/18PRICE SENSITIVE download Created with Sketch. 142.53KB
ZLD Appendix 4G
31/08/18 download Created with Sketch. 122.15KB
ZLD Appendix 4E & Financial Statements
31/08/18PRICE SENSITIVE download Created with Sketch. 953.66KB
ZLD Appendix 3B
22/08/18 download Created with Sketch. 149.64KB
ZLD Two Key Clinical Appointments to Medical Advisory Board
22/08/18 download Created with Sketch. 128.87KB
ZLD June 2018 Quarterly Report
30/07/18PRICE SENSITIVE download Created with Sketch. 126.27KB
ZLD Appendix 4C - quarterly
30/07/18PRICE SENSITIVE download Created with Sketch. 75.55KB
ZLD Initial Director's Interest Notice
16/07/18 download Created with Sketch. 30.18KB
ZLD Commencement of New Managing Director
16/07/18PRICE SENSITIVE download Created with Sketch. 159.29KB
ZLD Paediatric Brain Cancer Research Update
06/06/18 download Created with Sketch. 146.6KB
ZLD Details of Company Address
25/05/18 download Created with Sketch. 113.53KB
ZLD Appointment of Managing Director
22/05/18PRICE SENSITIVE download Created with Sketch. 124.53KB
ZLD March 2018 Quarterly Report
30/04/18PRICE SENSITIVE download Created with Sketch. 135.38KB
ZLD Appendix 4C - quarterly
30/04/18PRICE SENSITIVE download Created with Sketch. 75.01KB
ZLD Insomnia Clinical Trial Update-Patient Recruitment Completed
23/04/18PRICE SENSITIVE download Created with Sketch. 125.51KB
ZLD Research into Cannabinoids and Diabetes-Related Conditions
18/04/18 download Created with Sketch. 126.79KB
ZLD US Autism Observational Study Receives IRB Approval
13/04/18 download Created with Sketch. 144.11KB
ZLD Expansion of Pancreatic Cancer Research Programme
06/03/18PRICE SENSITIVE download Created with Sketch. 145.21KB
ZLD Appendix 4D & FY18 Interim Financial Report
27/02/18PRICE SENSITIVE download Created with Sketch. 289.5KB
ZLD December 2017 Quarterly Report
31/01/18 download Created with Sketch. 126.54KB
ZLD Appendix 4C - quarterly
31/01/18PRICE SENSITIVE download Created with Sketch. 74.93KB
ZLD Shares Begin Trading in the USA on the OTCQB Venture Market
22/01/18 download Created with Sketch. 123.81KB
ZLD Appendix 3B
12/01/18 download Created with Sketch. 148.22KB
ZLD Cancellation of Unlisted Options
10/01/18 download Created with Sketch. 86.22KB
ZLD Change of Director's Interest Notice
20/12/17 download Created with Sketch. 73.48KB
ZLD Zelda joins with US Children's Hospital for autism study
11/12/17PRICE SENSITIVE download Created with Sketch. 142.58KB
ZLD Trading Halt
08/12/17PRICE SENSITIVE download Created with Sketch. 364.62KB
ZLD Response to ASX Aware Query
05/12/17PRICE SENSITIVE download Created with Sketch. 578.75KB
ZLD Australian Regulators Approve Zelda Insomnia Clinical Trial
29/11/17PRICE SENSITIVE download Created with Sketch. 127.02KB
ZLD Results of Meeting
24/11/17 download Created with Sketch. 111.98KB
ZLD Annual General Meeting Presentation 2017
24/11/17 download Created with Sketch. 2.22MB
ZLD Chairman's Address - Annual General Meeting
24/11/17 download Created with Sketch. 61.23KB
ZLD Response to ASX Price and Volume Query
22/11/17PRICE SENSITIVE download Created with Sketch. 500.58KB
ZLD Trading Halt
21/11/17PRICE SENSITIVE download Created with Sketch. 308.37KB
ZLD Appendix 3B - Release of Securities from Escrow
16/11/17 download Created with Sketch. 147.55KB
ZLD Release from Escrow
01/11/17 download Created with Sketch. 89.4KB
ZLD September 2017 Quarterly Report
31/10/17 download Created with Sketch. 123.1KB
ZLD Appendix 4C - quarterly
31/10/17PRICE SENSITIVE download Created with Sketch. 80.31KB
ZLD Notice of Annual General Meeting
26/10/17 download Created with Sketch. 97.72KB
ZLD Successful Results in Autism Observation Trial
18/09/17PRICE SENSITIVE download Created with Sketch. 122.86KB
ZLD Update on Closing Date of CannPal Priority Offer
18/09/17 download Created with Sketch. 92.95KB
ZLD Update on Research Programme in Chile
13/09/17 download Created with Sketch. 124.26KB
ZLD Appendix 4G
31/08/17 download Created with Sketch. 113.46KB
ZLD Appendix 4E & Financial Statements
31/08/17PRICE SENSITIVE download Created with Sketch. 822.26KB
ZLD CannPal Priority Share Offer Clarification Announcement
31/08/17 download Created with Sketch. 91.75KB
ZLD Priority Share Offer for CannPal IPO Shares
29/08/17 download Created with Sketch. 93.19KB
ZLD Company Presentation on 2017 Half Year Activities
25/08/17 download Created with Sketch. 105.9KB
ZLD Expansion of Breast Cancer Research Collaboration
31/07/17PRICE SENSITIVE download Created with Sketch. 697.38KB
ZLD June 2017 Quarterly Report
28/07/17 download Created with Sketch. 147.88KB
ZLD Appendix 4C - quarterly
28/07/17PRICE SENSITIVE download Created with Sketch. 75.61KB
ZLD ENT:Acquisition of prospective Au& Cu/Zn Murchison Tenements
26/07/17PRICE SENSITIVE download Created with Sketch. 1016.08KB
ZLD Updated Securities Trading and Corporate Governance Policies
30/06/17 download Created with Sketch. 180.34KB
ZLD Zelda Enters into Strategic Agreement with Knop Laboratories
15/06/17PRICE SENSITIVE download Created with Sketch. 175.29KB
ZLD Positive Results From Pre-Clinical Breast Cancer Studies
02/06/17PRICE SENSITIVE download Created with Sketch. 228.16KB
ZLD March 2017 Quarterly Report
28/04/17PRICE SENSITIVE download Created with Sketch. 405.15KB
ZLD Appendix 4C - quarterly
28/04/17PRICE SENSITIVE download Created with Sketch. 240.11KB
ZLD Appendix 3B - Release of Securities from Escrow
21/04/17 download Created with Sketch. 122.93KB
ZLD Clinical Research Programme to Expand to Include Autism
19/04/17PRICE SENSITIVE download Created with Sketch. 431.74KB
ZLD Change in substantial holding x 3
06/04/17 download Created with Sketch. 556.09KB
ZLD Appendix 3B
05/04/17 download Created with Sketch. 125.25KB
ZLD Release from Escrow
04/04/17 download Created with Sketch. 64.22KB
ZLD Cleansing Prospectus
03/04/17PRICE SENSITIVE download Created with Sketch. 211.79KB
ZLD Zelda Successfully Completes Capital Raising
30/03/17PRICE SENSITIVE download Created with Sketch. 77.28KB
ZLD Trading Halt
28/03/17PRICE SENSITIVE download Created with Sketch. 289.56KB
ZLD Zelda Enters Strategic Partnership with CannPal
27/03/17PRICE SENSITIVE download Created with Sketch. 82.79KB
ZLD Clinical Trials to Commence in Chile
23/03/17PRICE SENSITIVE download Created with Sketch. 421.27KB
ZLD New Licence Agreement
21/03/17PRICE SENSITIVE download Created with Sketch. 106.58KB
ZLD Closure of Unmarketable Parcel Share Sale Facility
14/03/17 download Created with Sketch. 63.09KB
ZLD Appendix 4D & FY17 Interim Financial Report
27/02/17PRICE SENSITIVE download Created with Sketch. 250.99KB
ZLD Zelda Therapeutics to present activities update
21/02/17 download Created with Sketch. 38.46KB
ZLD Investor Presentation
08/02/17 download Created with Sketch. 631KB
ZLD Issue of Options under ESOP & Appendix 3B
06/02/17 download Created with Sketch. 146.44KB
ZLD Quarterly Report and Appendix 4C
31/01/17PRICE SENSITIVE download Created with Sketch. 276.75KB
ZLD Unmarketable Parcel Share Sale Facility
19/01/17 download Created with Sketch. 201.26KB
ZLD Appendix 3B
11/01/17 download Created with Sketch. 122.66KB
ZLD Release from escrow
11/01/17 download Created with Sketch. 26.2KB
ZLD Details of Company Address
11/01/17 download Created with Sketch. 26.24KB
ZLD Shareholder Update
09/01/17 download Created with Sketch. 87.19KB
ZLD Zelda to Test Formulations Against Pancreatic Cancer
20/12/16PRICE SENSITIVE download Created with Sketch. 60.39KB
ZLD Company Secretary Appointment
16/12/16 download Created with Sketch. 23.67KB
ZLD Sleep Disorder Clinical Trials Update
12/12/16PRICE SENSITIVE download Created with Sketch. 71.11KB
ZLD Collaboration Agreement with Telethon Kids Institute
05/12/16PRICE SENSITIVE download Created with Sketch. 71.08KB
ZLD Significant Anti-Cancer Effect Observed in Studies
30/11/16PRICE SENSITIVE download Created with Sketch. 152.06KB
ZLD Results of Meeting
28/11/16 download Created with Sketch. 26.45KB
ZLD Becoming a substantial holder
25/11/16 download Created with Sketch. 1.36MB
ZLD Change in substantial holding
25/11/16 download Created with Sketch. 1.46MB
ZLD Change in substantial holding
25/11/16 download Created with Sketch. 92.13KB
ZLD Zelda expands its Intellectual Property portfolio
25/11/16PRICE SENSITIVE download Created with Sketch. 340.99KB
ZLD Becoming a substantial holder
23/11/16 download Created with Sketch. 165.31KB
ZLD OpenBriefing Recording with Dr Stewart Washer
23/11/16PRICE SENSITIVE download Created with Sketch. 63.19KB
ZLD Investor Presentation
22/11/16 download Created with Sketch. 1.47MB
ZLD Zelda Therapeutics Debuts on ASX
22/11/16 download Created with Sketch. 73.19KB
ZLD Zelda Therapeutics Pty Ltd - 30 June 2016 Accounts
18/11/16 download Created with Sketch. 302.6KB
ZLD Zelda Therapeutics Pty Ltd - 31 December 2015 Accounts
18/11/16 download Created with Sketch. 1.27MB
ZLD Updated Pro-Forma Statement
18/11/16 download Created with Sketch. 158.87KB
ZLD Updated Statement of Commitments
18/11/16 download Created with Sketch. 362.28KB
ZLD Confirmations
18/11/16 download Created with Sketch. 31.94KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
38.0¢
Change
-0.030(7.32%)
Mkt cap ! $4.520M
Open High Low Value Volume
40.0¢ 42.0¢ 38.0¢ $1.766K 4.48K

Buyers (Bids)

No. Vol. Price($)
3 34234 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 5666 1
View Market Depth
Last trade - 15.50pm 15/09/2025 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.